PhD in Biomedical and Evolutionary Biotechnology

Academic year 2025-26

Degree data and benchmarks

Below are the main data and benchmarks, as well as the results of the satisfaction surveys for the degree programme, which are periodically analysed and monitored by the centre administrator, the head of studies and the corresponding quality assurance commissions, with a view to promoting the ongoing improvement of the programme.

 

Satisfaction of groups involved

Satisfaction index

 
2019-20 2020-21 2021-22 2022-23 2023-24
Student satisfaction - 3,50 - - 2,40
PDI satisfaction 3,14 3,28 3,14 3,25 3,00
PAS satisfaction 3,00 - - - 3,00

Description

Student, PDI and PAS satisfaction levels are rated on a scale of 1 to 4, where 1 means ‘not at all satisfied’ and 4 means ‘very satisfied’. They are obtained from the following surveys:

  • Survey of student satisfaction with the study programme (yearly)
  • Survey of satisfaction and identification of needs of teaching and research staff (PDI) (yearly)
  • Biennial survey of satisfaction and identification of needs of administrative and service staff (PAS) who have supported undergraduate and postgraduate studies.

 

Survey participation rates

 
2019-20 2020-21 2021-22 2022-23 2023-24
Student participation rate 16 % 19 % 15 % 20 % 43 %
PDI participation rate 32 % 32 % 27 % 22 % 44 %
PAS participation rate 50 % - - - 47 %

Description

Only the data that meet a double criterion of representativeness have been considered valid: on one hand, reaching 4 answered surveys and, on the other hand, that the number of answered surveys is equal to or greater than 15% of the population

Thesis

Link to the institutional repository (DSPACE)

Year Thesis
2025
  • Caracterización clínica y molecular de la Amiloidosis por Transtirretina en el foco endémico de Mallorca
2024
  • Contribución al conocimiento de los helmintos parásitos del erizo moruno Atelerix algirus (Mammalia: Erinaceidae) en Mallorca
  • Hydroxylated Fatty Acids as a Therapeutic Solution to Neuropathic Pain: Behavioural, Molecular and Clinical Approaches.
  • Integrative genomic, transcriptomic, and epigenomic theranostic biomarkers for patients with glioblastoma and triple negative breast cancer
  • Micro-immunotherapy as a therapeutic approach for periodontitis and osteoporosis: biocompatibility and preclinical efficacy evaluation
2023
  • Evaluation of genetic variability on intraclonal water use efficiency in Tempranillo cv
2022
  • DNA barcoding as a tool to study the evolution, trophic ecology and microbiota of insular lizards of the genus Podarcis (Squamata, Lacertidae).
  • Genetic And Genomic Analysis Of Amphipods Of The Genus Hyalella (Crustacea) In The Lake Titicaca Basin (Andean Altiplano)
  • Mecanismo antitumoral del ácido 2-hidroxioleico en glioblastoma: identificación de nuevos roles mediante análisis ómicos de membranas subcelulares y estudios biofísicos de membranas modelo
  • Seasonality, life cycle and vectorial capacity of Xylella fastidiosa insect vectors in the main crops of the Balearic Islands
  • The role of insecticides and repellents in protecting humans and as tools in the fight against vector- borne disease transmission
2021
  • "Estudi de la via de WNT com a diana terapèutica en tumors sòlids i identificació de nous marcadors pronòstics i predictius"
  • A NEW THERAPEUTIC TARGET FOR THE TREATMENT OF GLIOMA AND OTHER TYPES OF CANCER: DESIGN, RESEARCH, AND DEVELOPMENT OF GLUCOSYLCERAMIDE SYNTHASE INHIBITORS
  • Disentangling the genomic architecture of psychosis in families with high prevalence through system genomic approaches
  • Genetic analyses of adaptive processes in the Podarcis genus
  • INTERACCIONES LÍPIDO-PROTEÍNA DE MEMBRANA EN GLIOMA: EL ÁCIDO 2-HIDROXIOLEICO COMO INTERRUPTOR ANTIPROLIFERATIVO
  • USE OF THE LIPID FINGERPRINT FOR THE IDENTIFICATION OF NEW BIOMARKERS AND THERAPEUTIC TARGETS IN COLON CANCER
2019
  • "Bionomía y modelos de abundancia estacional de las especies del género Culicoides (Diptera; Ceratopogonidae) en España, con especial interés en los vectores del virus de la Lengua Azul."
  • "Eficacia y mecanismos de acción antitumoral de lípidos de diseño"
  • ESTUDIO DE LA REGULACIÓN DE LA EXPRESIÓN DE HES1 Y SU MODULACIÓN POR 2OHOA EN GLIOMA.